LakeShore Biopharma Co., Ltd
NASDAQ: LSB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Wang Xu
- Employees
- 758
- Headquarters
- Beijing, China
- IPO year
- 2021
- Market cap
- $25.8M
- Website
- https://www.ysbiopharm.com
Loading LSB…
Loading profile data…Frequently asked questions about LSB
What does LakeShore Biopharma Co., Ltd (LSB) do?
LakeShore Biopharma Co., Ltd is a biopharmaceutical firm focused on the discovery, advancement, manufacturing, and marketing of vaccines and therapeutic biologics. Its primary targets are infectious diseases and various forms of cancer. At the core of its innovation is a proprietary PIKA immunomodulating technology platform, which underpins its...
Where does LSB trade?
LakeShore Biopharma Co., Ltd (LSB) trades on the NASDAQ Capital Market.
What sector is LSB in?
LakeShore Biopharma Co., Ltd (LSB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of LakeShore Biopharma Co., Ltd?
Wang Xu is the chief executive officer of LakeShore Biopharma Co., Ltd (LSB).
Where is LakeShore Biopharma Co., Ltd headquartered?
LakeShore Biopharma Co., Ltd is headquartered in China.
Does LSB pay a dividend?
LakeShore Biopharma Co., Ltd (LSB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LSB go public?
LakeShore Biopharma Co., Ltd (LSB) completed its initial public offering in 2021.